Business Description
Predictive Oncology Inc
NAICS : 339112
SIC : 3841
ISIN : US74033P1003
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.29 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.22 | |||||
Debt-to-EBITDA | -0.18 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -38.91 | |||||
Beneish M-Score | -2.86 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -40.4 | |||||
3-Year EBITDA Growth Rate | 44.5 | |||||
3-Year EPS without NRI Growth Rate | 48 | |||||
3-Year FCF Growth Rate | 45.8 | |||||
3-Year Book Growth Rate | -8.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 131.26 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.28 | |||||
9-Day RSI | 32.83 | |||||
14-Day RSI | 40.31 | |||||
6-1 Month Momentum % | -19.46 | |||||
12-1 Month Momentum % | -77.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 0.81 | |||||
Days Inventory | 221.99 | |||||
Days Sales Outstanding | 107.74 | |||||
Days Payable | 629.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -60.1 | |||||
Shareholder Yield % | -6.68 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.94 | |||||
Operating Margin % | -960.19 | |||||
Net Margin % | -920.9 | |||||
FCF Margin % | -876.14 | |||||
ROE % | -232.54 | |||||
ROA % | -114 | |||||
ROIC % | -291.56 | |||||
ROC (Joel Greenblatt) % | -408.13 | |||||
ROCE % | -181.2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.06 | |||||
PB Ratio | 2.29 | |||||
Price-to-Tangible-Book | 2.64 | |||||
EV-to-EBIT | -0.27 | |||||
EV-to-EBITDA | -0.29 | |||||
EV-to-Revenue | 2.58 | |||||
EV-to-Forward-Revenue | 0.42 | |||||
EV-to-FCF | -0.29 | |||||
Price-to-Median-PS-Value | 0.23 | |||||
Earnings Yield (Greenblatt) % | -370.37 | |||||
FCF Yield % | -290.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:POAI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Predictive Oncology Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1.517 | ||
EPS (TTM) ($) | -3.05 | ||
Beta | 1.96 | ||
Volatility % | 55.68 | ||
14-Day RSI | 40.31 | ||
14-Day ATR ($) | 0.064067 | ||
20-Day SMA ($) | 0.768478 | ||
12-1 Month Momentum % | -77.22 | ||
52-Week Range ($) | 0.55 - 3.76 | ||
Shares Outstanding (Mil) | 6.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Predictive Oncology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Predictive Oncology Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Predictive Oncology Inc Frequently Asked Questions
What is Predictive Oncology Inc(POAI)'s stock price today?
When is next earnings date of Predictive Oncology Inc(POAI)?
Does Predictive Oncology Inc(POAI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |